Govorestat failed to meet its primary endpoint in a Phase II/III trial for a rare form of Charcot-Marie-Tooth disease, a few ...

Alan Jackson is saying goodbye to the stage, but not before one final show in Nashville in 2026. Here's what he had to say.

Applied Therapeutics’ rare disease drug has failed another late-stage clinical trial, adding to the woes of a candidate that ...

Alan announced back in 2021 that he was suffering from Charcot-Marie-Tooth disease, a degenerative nerve condition that made it hard for the country music legend to stand and keep his balance.

"It’s been a long, sweet ride," the country-music star told fans during his show in Milwaukee on Saturday, May 17 ...

"Y’all may have heard that I’m kinda winding down," Jackson said Saturday. "In fact, this is my last road show of my career.

The famous country music singer wrapped up his final stop on tour with an emotional speech addressing his incurable disease.

Home > Press release: Study launched to identify new ...

Jackson, 66, has been battling Charcot-Marie-Tooth disease for years, an inheritable disease that causes "lifelong progressive muscle weakness and atrophy of the arms and legs," per the ...

He was diagnosed with Charcot-Marie-Tooth which he said was “starting to affect my performance onstage a little bit where I ...

Charcot-Marie-Tooth disease (CMT) is one of the most common hereditary neurological diseases worldwide. It affects around one in 2,500 people and is therefore classed as a “rare disease”.

USA-based rare disease company Applied Therapeutics (Nasdaq: APLT) saw its shares rise nearly 23% to $0.60 on Friday, ahead ...